Royal Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.20 M
- Paid Up Capital ₹ 2.20 M
- Company Age 28 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 M
- Revenue Growth 275.90%
- Profit Growth 121.40%
- Ebitda 162.21%
- Net Worth 83.03%
- Total Assets 22.04%
About Royal Life Sciences
Royal Life Sciences Private Limited (RLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 April 1996 and has a history of 28 years and nine months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Kerti Solutions Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.20 M and a paid-up capital of Rs 2.20 M.
The company currently has active open charges totaling ₹8.00 M.
Dipender Singh and Akhil Pandey serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51900TG1996PTC023799
-
Company No.
023799
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Apr 1996
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Royal Life Sciences Private Limited offer?
Royal Life Sciences Private Limited offers a wide range of products and services, including Oil Testing Services, Edible Oil Testing, Diagnostic Imaging & Pathology Labs, Medical Test Services, Graduation & High Education Programs, Medical Educational Service, Material Testing Labs & Services, Testing Services, Agricultural & Farm Consultants, Agricultural Testing Service.
Who are the key members and board of directors at Royal Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipender Singh
|
Managing Director | 15-Apr-1996 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Akhil Pandey
|
Director | 13-May-2022 | Current |
Financial Performance of Royal Life Sciences.
Royal Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 275.9% increase. The company also saw a substantial improvement in profitability, with a 121.4% increase in profit. The company's net worth Soared by an impressive increase of 83.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Royal Life Sciences?
In 2022, Royal Life Sciences had a promoter holding of 81.73% and a public holding of 18.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Logical Nutritional Solutions Private LimitedDipender Singh is a mutual person
-
Microbial Research Lab Private Limited
Dipender Singh is a mutual person
Charges (Loans)
₹8.00 M
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2003 | Syndicate Bank | ₹8.00 M | Open |
How Many Employees Work at Royal Life Sciences?
Unlock and access historical data on people associated with Royal Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Royal Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Royal Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
